The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(2-azidoacetamido)-N-((S)-1-(cyanomethylamino)-4-methyl-1-oxopentan-2-yl)-4-methylpentanamide ID: ALA3357961
PubChem CID: 118722554
Max Phase: Preclinical
Molecular Formula: C16H27N7O3
Molecular Weight: 365.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C[C@H](NC(=O)CN=[N+]=[N-])C(=O)N[C@@H](CC(C)C)C(=O)NCC#N
Standard InChI: InChI=1S/C16H27N7O3/c1-10(2)7-12(15(25)19-6-5-17)22-16(26)13(8-11(3)4)21-14(24)9-20-23-18/h10-13H,6-9H2,1-4H3,(H,19,25)(H,21,24)(H,22,26)/t12-,13-/m0/s1
Standard InChI Key: LFKAXBWLDYOUJZ-STQMWFEESA-N
Molfile:
RDKit 2D
26 25 0 0 0 0 0 0 0 0999 V2000
2.6823 -2.6890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1017 -2.1131 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5194 -1.5347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2172 -3.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9249 -2.6951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2172 -3.9209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6326 -3.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3404 -2.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0481 -3.1037 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3404 -1.8779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7558 -2.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6326 -3.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4635 -3.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1679 -3.5104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3372 -4.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0414 -3.9213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5131 -2.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3371 -5.1466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8045 -3.1022 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5149 -1.8779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2235 -1.4709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2252 -0.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9303 -1.8810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0977 -2.6921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3891 -3.0991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0995 -1.8749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 2 0
4 5 1 0
4 6 2 0
5 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
7 12 1 6
12 15 1 0
11 13 1 0
13 14 3 0
16 15 1 0
4 17 1 0
15 18 1 0
17 19 1 0
17 20 1 1
20 21 1 0
21 22 1 0
21 23 1 0
19 24 1 0
24 25 1 0
24 26 2 0
25 1 1 0
M CHG 2 2 1 3 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.44Molecular Weight (Monoisotopic): 365.2175AlogP: 1.00#Rotatable Bonds: 11Polar Surface Area: 159.85Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: -10.25CX Basic pKa: ┄CX LogP: 0.17CX LogD: 0.05Aromatic Rings: ┄Heavy Atoms: 26QED Weighted: 0.22Np Likeness Score: -0.29
References 1. Wammes AE, Hendriks TG, Amatdjais-Groenen HI, Wijdeven MA, van Hest JC, van Delft FL, Ritschel T, Rutjes FP.. (2014) Influence of azide incorporation on binding affinity by small papain inhibitors., 22 (20): [PMID:24972724 ] [10.1016/j.bmc.2014.06.001 ]